Logo-bi
Review
Ailar Nakhlband, Jaleh Barar* ORCID
Bioimpacts. 2011;1(1): 7-22. doi: 10.5681/bi.2011.003
PMCID: PMC3648943     PMID: 23678403     Scopus ID: 84876715577    
PDF
XML
Cited By:
Review
Sanjay Singh*
Bioimpacts. 2013;3(2): 53-65. doi: 10.5681/bi.2013.007
PMCID: PMC3713871     PMID: 23878788     Scopus ID: 84881502609    
PDF
XML
Cited By:
Review
Jaleh Barar* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2014;4(1): 3-14. doi: 10.5681/bi.2014.011
PMCID: PMC4005281     PMID: 24790893     Scopus ID: 84898640100    
PDF
XML
Cited By:
Review
Yadollah Omidi ORCID, Jaleh Barar* ORCID
Bioimpacts. 2014;4(2): 55-67. doi: 10.5681/bi.2014.021
PMCID: PMC4097973     PMID: 25035848     Scopus ID: 84905435584    
Review
Omid Mashinchian, Mohammad Johari-Ahar, Behnaz Ghaemi, Mohammad Rashidi, Jaleh Barar* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2014;4(3): 149-166. doi: 10.15171/bi.2014.008
PMCID: PMC4204040     PMID: 25337468     Scopus ID: 84908221773    
Editorial
Jaleh Barar* ORCID
Bioimpacts. 2015;5(3): 113-115. doi: 10.15171/bi.2015.23
PMCID: PMC4597157     PMID: 26457247     Scopus ID: 84944413654    
PDF
XML
Cited By:
Scientific Analysis
Mohammad-Hossein Biglu*, Shukuh Riazi
Bioimpacts. 2015;5(4): 199-205. doi: 10.15171/bi.2015.29
PMCID: PMC4769790     PMID: 26929924     Scopus ID: 84958171904    
PDF
XML
Cited By:
Editorial
Yadollah Omidi* ORCID
Bioimpacts. 2011;1(4): 199-201. doi: 10.5681/bi.2011.028
PMCID: PMC3648969     PMID: 23678428     Scopus ID: 84876726247    
PDF
XML
Cited By:
Editorial
Yadollah Omidi* ORCID
Bioimpacts. 2011;1(3): 145-147. doi: 10.5681/bi.2011.019
PMCID: PMC3648960     PMID: 23678419     Scopus ID: 84865491877    
PDF
XML
Cited By:
Review
Yadollah Omidi* ORCID, Jaleh Barar ORCID
Bioimpacts. 2012;2(1): 5-22. doi: 10.5681/bi.2012.002
PMCID: PMC3648919     PMID: 23678437     Scopus ID: 84876731279    
PDF
XML
Cited By:
Review
Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2012;2(3): 127-143. doi: 10.5681/bi.2012.025
PMCID: PMC3648930     PMID: 23678451     Scopus ID: 84874512835    
PDF
XML
Cited By:
Review
Marziyeh Fathi, Parham Sahandi Zangabad, Sima Majidi, Jaleh Barar, Hamid Erfan-Niya, Yadollah Omidi* ORCID
Bioimpacts. 2017;7(4): 269-277. doi: 10.15171/bi.2017.32
PMCID: PMC5801539     PMID: 29435435     Scopus ID: 85041008382    
Review
Ailar Nakhlband, Morteza Eskandani, Yadollah Omidi ORCID, Nazli Saeedi, Samad Ghafari, Jaleh Barar* ORCID, Alireza Garjani*
Bioimpacts. 2018;8(1): 59-75. doi: 10.15171/bi.2018.08
PMCID: PMC5915710     PMID: 29713603     Scopus ID: 85044298919    
Original Research
Ayuob Aghanejad, Hiwa Babamiri, Khosro Adibkia, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2018;8(2): 117-127. doi: 10.15171/bi.2018.14
PMCID: PMC6026525     PMID: 29977833     Scopus ID: 85048082430    
Editorial
Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2019;9(2): 67-70. doi: 10.15171/bi.2019.09
PMCID: PMC6637218     PMID: 31334037     Scopus ID: 85067455587    
Aptamers (Aps) are short single-strand nucleic acids, which can be used as the therapeutic and targeting agent in advanced drug delivery systems. Conjugation of Aps with other entities (siRNA, toxins, drugs, DNAzyme/Ribozymes) provides advanced multifunctional nanosystems for cancer therapy.
Editorial
Mostafa Akbarzadeh Khiavi ORCID, Azam Safary ORCID, Mohammad Hossein Somi* ORCID
Bioimpacts. 2019;9(3): 123-127. doi: 10.15171/bi.2019.16
PMCID: PMC6726747     PMID: 31508327     Scopus ID: 85071152476    
Colorectal cancer (CRC) as a malignancy shows high mortality rate worldwide because of metastasis and drug resistance. Targeted multimodal nanosystems (NSs) can be developed and used against CRC with much better clinical outcomes.
Original Research
Mostafa Akbarzadeh Khiavi ORCID, Azam Safary ORCID, Jaleh Barar ORCID, Hamed Farzi-Khajeh, Abolfazl Barzegari, Rahimeh Mousavi, Mohammad Hossein Somi* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2020;10(1): 27-36. doi: 10.15171/bi.2020.04
PMCID: PMC6977588     PMID: 31988854     Scopus ID: 85078959970    
The current study introduces an efficient ROS-responsive enzyme-based nanobiosystem and its biological impact in colon cancer therapy. Based on physicochemical properties, AuNPs-PEG-RNase A effectively induced apoptosis in SW-480 colon cancer cells and resulted in a significant reduction in cancer cell viability.
Editorial COVID-19
Jaleh Barar* ORCID
Bioimpacts. 2020;10(3): 137-138. doi: 10.34172/bi.2020.16
PMCID: PMC7416010     PMID: 32793434     Scopus ID: 85089709760    
The vast knowledge about the pathways that regulate the virus entry and molecular signaling of the pathogenesis of coronavirus are the key factor for the development of de novo nanoscaled diagnostic/therapeutic strategies.
Original Research
Efthymia-Iliana Matthaiou ORCID, Yi Guo, Jaleh Barar ORCID, Raphael Sandaltzopoulos, Lana E. Kandalaft, Chunsheng Li*, George Coukos, Yadollah Omidi* ORCID
Bioimpacts. 2022;12(1): 65-86. doi: 10.34172/bi.2021.23511
PMCID: PMC8783079     PMID: 35087718     Scopus ID: 85127176631    
Poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) functionalized with polyethylene glycol (PEG)and anti-TEM1 antibody fragment (78Fc) and loaded with necrosis-inducing agent shikonin (SHK)(78Fc-PLGA-SHK NPs) is a highly effective immunostimulating nanomedicine against theTEM1-expressing cells for targeted therapy of solid tumors.
Editorial
Nazanin Kianinejad ORCID, Young Min Kwon* ORCID
Bioimpacts. 2023;13(1): 1-3. doi: 10.34172/bi.2022.26321
PMCID: PMC9923813     PMID: 36816997     Scopus ID: 85152111029    
Young M. Kwon is an associate professor of Pharmaceutical Sciences at Nova Southeastern University, College of Pharmacy (USA). Dr. Kwon’s research interests include targeted delivery and controlled release of biological molecules.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge